Literature DB >> 9440384

Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants.

C Guerin-Danan1, C Chabanet, C Pedone, F Popot, P Vaissade, C Bouley, O Szylit, C Andrieux.   

Abstract

Ingestion of fermented dairy products induces changes in the equilibrium and metabolism of the intestinal microflora and may thus exert a healthful influence on the host. We compared the effects of consumption of a traditional yogurt, a milk fermented with yogurt cultures and Lactobacillus casei (YC), and a nonfermented gelled milk on the fecal microflora of healthy infants. Thirty-nine infants aged 10-18 mo were randomly assigned to one of three groups in which they received 125 g/d of one of the three products for 1 mo. The following indexes were not modified during the supplementation period or for 1 wk after the end of supplementation: total number of anaerobes, bifidobacteria, bacteroides, and enterobacteria; pH; water content; concentrations of acetate, butyrate, propionate, and lactate; and bacterial enzyme activity of beta-galactosidase and alpha-glucosidase. In contrast, in the yogurt group the number of enterococci in fecal samples increased (P < 0.05), whereas the percentage of branched-chain and long-chain fatty acids, which are markers of proteolytic fermentation, decreased (P < 0.05). In the YC group, the percentage of children with > 6 log10 colony-forming units lactobacilli/g feces increased (P < 0.05), whereas the potentially harmful enzyme activity of beta-glucuronidase and beta-glucosidase decreased (P < 0.05). These decreases were particularly marked in those infants in the YC group in whom activity of the enzymes was initially unusually high.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440384     DOI: 10.1093/ajcn/67.1.111

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors:  N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk.

Authors:  Raish Oozeer; Antony Leplingard; Denis D G Mater; Agnès Mogenet; Rachel Michelin; Isabelle Seksek; Philippe Marteau; Joël Doré; Jean-Louis Bresson; Gérard Corthier
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

3.  Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells.

Authors:  Isabelle Ingrassia; Antony Leplingard; Arlette Darfeuille-Michaud
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

4.  Efficacy of Lactic Acid Bacteria (LAB) supplement in management of constipation among nursing home residents.

Authors:  Hyang Mi An; Eun Hye Baek; Seok Jang; Do Kyung Lee; Mi Jin Kim; Jung Rae Kim; Kang Oh Lee; Jong Gi Park; Nam Joo Ha
Journal:  Nutr J       Date:  2010-02-05       Impact factor: 3.271

5.  Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial.

Authors:  D Merenstein; M Murphy; A Fokar; R K Hernandez; H Park; H Nsouli; M E Sanders; B A Davis; V Niborski; F Tondu; N M Shara
Journal:  Eur J Clin Nutr       Date:  2010-05-19       Impact factor: 4.016

6.  Luminal fermentation and colonocyte metabolism in a rat model of enteral nutrition.

Authors:  Corentin Babakissa; Virginie Colomb; Claude Andrieux; Claire Cherbuy; Pierre Vaugelade; Françoise Bernard; Françoise Popot; Odile Corriol; Claude Ricour; Pierre-Henri Duée; Béatrice Darcy-Vrillon
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

7.  Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice.

Authors:  R Oozeer; N Goupil-Feuillerat; C A Alpert; M van de Guchte; J Anba; J Mengaud; G Corthier
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

8.  An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties.

Authors:  Dora I A Pereira; Anne L McCartney; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

9.  Manipulating the gut microbiota to maintain health and treat disease.

Authors:  Karen P Scott; Jean-Michel Antoine; Tore Midtvedt; Saskia van Hemert
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

Review 10.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.